JP2014094963A5 - - Google Patents

Download PDF

Info

Publication number
JP2014094963A5
JP2014094963A5 JP2014009382A JP2014009382A JP2014094963A5 JP 2014094963 A5 JP2014094963 A5 JP 2014094963A5 JP 2014009382 A JP2014009382 A JP 2014009382A JP 2014009382 A JP2014009382 A JP 2014009382A JP 2014094963 A5 JP2014094963 A5 JP 2014094963A5
Authority
JP
Japan
Prior art keywords
pdt
use according
light
hexyl ester
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014009382A
Other languages
English (en)
Other versions
JP2014094963A (ja
JP5827702B2 (ja
Filing date
Publication date
Priority claimed from GBGB0700580.4A external-priority patent/GB0700580D0/en
Application filed filed Critical
Publication of JP2014094963A publication Critical patent/JP2014094963A/ja
Publication of JP2014094963A5 publication Critical patent/JP2014094963A5/ja
Application granted granted Critical
Publication of JP5827702B2 publication Critical patent/JP5827702B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (6)

  1. 膣腔、子宮頸部または子宮の内層のウイルス感染の治療のための動物に対する光線力学的療法(PDT)に用いる組成物の製造における、5−アミノレブリン酸(5−ALA)ヘキシルエステルまたはその薬剤として使用し得る塩の使用であって、該PDTは(a)、(b)を含み:(a)該組成物を該動物に投与すること;および
    (b)該5−ALAヘキシルエステルを光活性化すること、
    (i)と(iii)とを組み合わせて用いることによって、該PDTによる副作用を抑えるかあるいは少なくする:
    (i)該組成物が、0.5〜6重量%の濃度で該5−ALAヘキシルエステルを含むこと、
    (iii)該光活性化が、発光ダイオード(LED)からなり、フルエンス率が5〜40mW/cm2の光源を用いて行われることを特徴とする使用。
  2. 上記PDTによる副作用が、痛みおよび/または紅斑である請求項1に記載の使用。
  3. 上記組成物が5−ALAヘキシルエステルの塩酸塩を含む、請求項1または2に記載の使用。
  4. 上記光活性化が400〜700nmの波長範囲の光で行われる請求項1〜3のいずれか一項に記載の使用。
  5. 上記PDTが40〜200J/cm2の光線量で行われる請求項1〜4のいずれかに記載の使用。
  6. 上記PDTが100J/cm2の光線量で行われる請求項5に記載の使用。
JP2014009382A 2007-01-11 2014-01-22 アミノレブリン酸およびその誘導体の使用 Active JP5827702B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0700580.4 2007-01-11
GBGB0700580.4A GB0700580D0 (en) 2007-01-11 2007-01-11 Use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009545231A Division JP5814508B2 (ja) 2007-01-11 2008-01-11 アミノレブリン酸およびその誘導体の使用

Publications (3)

Publication Number Publication Date
JP2014094963A JP2014094963A (ja) 2014-05-22
JP2014094963A5 true JP2014094963A5 (ja) 2014-10-02
JP5827702B2 JP5827702B2 (ja) 2015-12-02

Family

ID=37809842

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009545231A Expired - Fee Related JP5814508B2 (ja) 2007-01-11 2008-01-11 アミノレブリン酸およびその誘導体の使用
JP2014009382A Active JP5827702B2 (ja) 2007-01-11 2014-01-22 アミノレブリン酸およびその誘導体の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009545231A Expired - Fee Related JP5814508B2 (ja) 2007-01-11 2008-01-11 アミノレブリン酸およびその誘導体の使用

Country Status (13)

Country Link
US (4) US8759396B2 (ja)
EP (3) EP2120921B1 (ja)
JP (2) JP5814508B2 (ja)
KR (2) KR20090118925A (ja)
CN (3) CN104069493A (ja)
CA (2) CA2675334C (ja)
DK (1) DK2120921T3 (ja)
ES (2) ES2900528T3 (ja)
GB (1) GB0700580D0 (ja)
PL (1) PL2120921T3 (ja)
PT (1) PT2120921E (ja)
SI (1) SI2120921T1 (ja)
WO (1) WO2008084241A2 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110224598A1 (en) * 2010-03-12 2011-09-15 Daniel Barolet Radiant near infrared light emitting diode exposure as skin preparation
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
WO2010142457A1 (en) * 2009-06-11 2010-12-16 Photocure Asa Semi-solid compositions and pharmaceutical products
CA2790827A1 (en) * 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
JP6323978B2 (ja) 2010-12-24 2018-05-16 アークレイ株式会社 癌細胞の検出方法
CN102617378B (zh) * 2011-01-26 2016-04-27 上海泺安医药技术有限公司 一种2-(3’-氨基-2’-氧-丙基)丙二酸酯盐及制备
KR101254752B1 (ko) * 2011-02-28 2013-04-15 부산대학교 산학협력단 광역동치료의 광증감제로 사용하기 위한 구연산을 이용한 아미노레불리닉산 트라이머
KR101254758B1 (ko) * 2011-02-28 2013-04-15 부산대학교병원 광역동치료의 광증감제로 사용하기 위한 이디티에이를 이용한 아미노레불리닉산 테트라머
CN102179010B (zh) * 2011-05-27 2013-01-09 吉林大学 脑胶质瘤光动力直接照射治疗装置
US20140350454A1 (en) * 2011-12-19 2014-11-27 Photocure Asa Irradiation apparatus
US9517267B2 (en) * 2012-01-26 2016-12-13 Sbi Pharmaceuticals Co., Ltd. Photodynamic diagnostic agent and photobleaching inhibitor
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
KR20150004092A (ko) * 2013-07-02 2015-01-12 제너럴바이오(주) 칼란코에 추출물이 포함된 항산화 액상 조성물
US10716855B2 (en) * 2013-12-20 2020-07-21 Galderma Research & Development Pulse photodynamic treatment of photodamaged skin
PL229756B1 (pl) 2014-11-12 2018-08-31 Tarchominskie Zaklady Farmaceutyczne Polfa Spólka Akcyjna Krem do stosowania w diagnostyce i terapii z zastosowaniem metody fotodynamicznej
WO2016080096A1 (ja) * 2014-11-19 2016-05-26 シャープ株式会社 光線力学治療装置
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
WO2017066270A1 (en) 2015-10-15 2017-04-20 Dusa Pharmaceuticals, Inc. Adjustable illuminator for photodynamic therapy and diagnosis
SG11201805000RA (en) 2015-12-17 2018-07-30 Photocure Asa Method of photodynamic therapy (pdt) for bladder cancer
US10632324B2 (en) 2017-04-27 2020-04-28 9127-4910 Quebec Inc. Method for the treatment of skin tissues
JP7454492B2 (ja) * 2017-07-17 2024-03-22 デューサ ファーマシューティカルズ インコーポレイテッド 皮膚障害に対する光線力学的治療方法
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
WO2020038583A1 (en) * 2018-08-23 2020-02-27 Biofrontera Bioscience Gmbh Photodynamic therapy comprising two light exposures at different wavelengths
EP3960241A4 (en) 2019-04-26 2023-06-07 Neopharma Japan Co., Ltd. THERAPEUTIC AGENT FOR FLAVIVIRUS INFECTION
US20220362573A1 (en) * 2019-06-25 2022-11-17 Dusa Pharmaceuticals, Inc. Methods for reducing pain during photodynamic therapy of actinic keratosis
CN115916178A (zh) * 2020-07-15 2023-04-04 日本纽翱医药股份有限公司 非洲猪瘟(African Swine Fever:ASF)的治疗剂和/或预防剂
CN113620828A (zh) * 2021-08-17 2021-11-09 湖南复瑞生物医药技术有限责任公司 一种5-氨基酮戊酸酯化物、用途和农药组合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5422093A (en) 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5955490A (en) 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
EP0820432B1 (en) 1995-03-10 2001-06-13 PhotoCure ASA Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
AUPQ044499A0 (en) 1999-05-19 1999-06-10 Commonwealth Scientific And Industrial Research Organisation Control of wool growth
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
EP2269645A3 (en) 2000-08-16 2011-01-12 The General Hospital Corporation doing business as Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
WO2003086460A2 (en) 2002-04-05 2003-10-23 Candela Corporation High fluence rate activation of photosensitizers for dermatological applications
US20040048842A1 (en) 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
AU2003301267A1 (en) 2002-10-18 2004-05-04 The Regents Of The University Of California Photodynamic therapy for ocular neovascularization
US20050209331A1 (en) 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
US20050209330A1 (en) 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) * 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product

Similar Documents

Publication Publication Date Title
JP2014094963A5 (ja)
EP2754439A3 (en) Use of aminolevulinic acid derivatives
CL2019001079A1 (es) Métodos para usar indazol-3-carboxamidas y su uso como inhibidores de la vía de señalización de wnt/b-catenina.
UY38263A (es) Compuestos de purinona y su uso en el tratamiento del cáncer
CO2018010748A2 (es) Agentes antivirales contra la hepatitis b
CY1124000T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
CY1121826T1 (el) Προφαρμακα καρβιντοπας και l-ντοπας και η χρηση τους στην αγωγη της νοσου parkinson
CY1119148T1 (el) Φαρμακευτικες συνθεσεις και συναφεις μεθοδοι χορηγησης
EA201490647A1 (ru) Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции
WO2014141110A3 (en) Aminonitriles as kynurenine pathway inhibitors
BRPI1002601E2 (pt) composição nanoestruturada de uso veterinário para administração de fármacos
JP2011098207A5 (ja)
CR20130377A (es) Métodos y productos de fármaco para tratar enfermedad de alzheimer
JP2011102304A5 (ja)
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
NZ703989A (en) Alkoxy pyrazoles as soluble guanylate cyclase activators
EA201591378A1 (ru) Композиции неорганических наночастиц в комбинации с ионизирующим излучением для лечения рака
AR112284A1 (es) Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
JP2017503785A5 (ja)
ATE543492T1 (de) Behandlung von lungenkrebs
JP2015516419A5 (ja)
CO6592015A2 (es) Métodos y composiciones para reducir o prevenir la cladificación vascular durante el tratamiento de diálisis peritoneal
CL2017000382A1 (es) Compuestos bicíclicos sustituidos